Top Markets
Coin of the day
AiXin Life International, Inc. AiXin Life International, Inc.

AiXin Life International, Inc.

AIXN
Hisse Senetlerindeki Sıralama #33968
AiXin Life International, Inc. develops, manufactures, markets, and sells... AiXin Life International, Inc. develops, manufactures, markets, and sells healthcare, nutritional products, and wellness supplements in the People's Republic of China. The company operates through four segments: Direct Sales, Pharmacy, Hotel, and Manufacture and Sale. It offers herbs, greens, and traditional Chinese remedies; and functional products, such as weight management tools, probiotics, and foods and drinks; and rhino king, colostrum powder derived from goat’s milk, tong li ke, gammaoling granules, amoxicillin capsules, loratadine tablets, and fuyang granules. The company also engages in hotel business. It provides products manufactured by the company and purchased from third parties, as well as marketing and distribution services to other manufacturers and suppliers of healthcare products. The company sells its products through company-owned offices open to clients, pharmacies, direct marketing, e-commerce, exhibition events, conferences, and person-to-person marketing. The company is based in Chengdu, China.
Hisse Fiyatı
$0.26
Son senkronizasyon: 2026-08-13
Piyasa Değeri
$6.50M
Değişim (1 gün)
0.00%
Değişim (1 yıl)
152.43%
Ülke
CN
Ticaret AiXin Life International, Inc. (AIXN)

Kategori

AiXin Life International, Inc. (AIXN) için kazanç
2026 itibarıyla kazanç TTM: 0
AiXin Life International, Inc. şirketinin en son finansal raporlarına göre, mevcut kazancı 0'dir. 2026 yılında şirket 0 kazanç elde etti, bu 2026 yılındaki 0 kazanca göre önceki yıla eşit. Bu sayfada gösterilen kazanç, faiz ve vergiler öncesi kazançtır; yani EBIT.
AiXin Life International, Inc. için kazanç geçmişi 2026 - 2026
Her yılın sonundaki kazanç
Yıl Kazanç Değiştir
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakipler için kazanç
Şirket Kazanç Kazanç Farkı Ülke
$6.46B -
US
- -
US
$2.17B -
US
- -
US
$358.16M -
AU